Olivier Brandicourt

Insider Reports History

Entity
Individual
Location
Pfizer Inc. Attn. Corp. Secretary, 235 East 42 Nd Street, New York, NY
Signature
/s/ Qing Nian, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Brandicourt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Director Ordinary Shares 16.3K $3.39M $207.72 Jun 5, 2024 Direct
BeiGene, Ltd. Director Share Option (Right to Buy) 34.2K Jun 5, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 5.23K May 16, 2024 Direct

Insider Reports Filed by Olivier Brandicourt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BGNE BeiGene, Ltd. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 16, 2024 1 $0 4 May 20, 2024 Director
BGNE BeiGene, Ltd. Feb 29, 2024 1 $0 4 Mar 4, 2024 Director
BGNE BeiGene, Ltd. Jan 23, 2024 0 $0 3 Jan 23, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2023 1 $0 4 May 19, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2022 1 $0 4 May 20, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director